7 Results for "

EIDD1931

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "EIDD1931" in MCE Product Catalog:

43
43 Cited Publications
Cat. No.: HY-125033
CAS No.: 3258-02-4
Purity:  99.96%
Synonyms: β-D-N4-hydroxycytidine; NHC
Research Areas:  

Infection

EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) is a novel nucleoside analog and behaves as a potent anti-virus agent. EIDD-1931 effectively inhibits the replication activity of venezuelan equine encephalitis virus (VEEV), Chikungunya virus (CHIKV) and hepatitis C virus (HCV) .
loading...
    loading...
79
79 Cited Publications
Cat. No.: HY-135853
CAS No.: 2492423-29-5
Purity:  99.85%
Synonyms: EIDD-2801; MK-4482
Research Areas:  

Infection

Molnupiravir (EIDD-2801) is an orally bioavailable proagent of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza .
loading...
    loading...
Cat. No.: HY-145668
CAS No.: 90597-20-9
Purity:  ≥99.0%
Research Areas:  

Infection Cancer

Cyclopentenyl uracil is a non-cytotoxic Uridine-Cytidine Kinase inhibitor and an antagonist of EIDD-1931 (NHC) (HY-125033) bioactivation. Cyclopentenyl uracil blocks NHC phosphorylation by inhibiting UCK1/UCK2, reduces intracellular NHC-TP accumulation, and depletes UTP/CTP pools, thereby antagonizing the antiviral activity of NHC and inhibiting dengue virus replication. Cyclopentenyl uracil is used in research on SARS-CoV-2 infection, dengue virus infection, leukemia, and solid tumors .
loading...
    loading...
Cat. No.: HY-135853S
Purity:  99.86%
Synonyms: EIDD-2801-d7; MK-4482-d7
Molnupiravir-d7 is the deuterium labeled Molnupiravir. Molnupiravir (EIDD-2801) is an orally bioavailable prodrug of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza .
loading...
    loading...
Cat. No.: HY-125033S1
CAS No.: 1955549-12-8
Synonyms: β-D-N4-hydroxycytidine-d2; NHC-d2
EIDD-1931-d2 is the deuterium labeled 3,6-Dichloro-2-methoxybenzoic acid .
loading...
    loading...
Cat. No.: HY-135853R
CAS No.: 2492423-29-5
Synonyms: EIDD-2801 (Standard); MK-4482 (Standard)
Research Areas:  

Infection

Molnupiravir (Standard) is the analytical standard of Molnupiravir. This product is intended for research and analytical applications. Molnupiravir (EIDD-2801) is an orally bioavailable proagent of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza .
loading...
    loading...
Cat. No.: HY-W754608
Synonyms: β-D-N4-Hydroxycytidine-13C,15N2; NHC-13C,15N2
EIDD 1931- 13C, 15N2 (β-D-N4-Hydroxycytidine- 13C, 15N2) is the 13C- and 15N-labeled EIDD 19312 (HY-125033). EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) is a novel nucleoside analog and behaves as a potent?anti-virus agent. EIDD-1931 effectively inhibits the replication activity of?venezuelan equine encephalitis?virus (VEEV),?Chikungunya?virus (CHIKV) and?hepatitis?C virus (HCV)
loading...
    loading...